Thu, Oct 2, 2014, 2:47 AM EDT - U.S. Markets open in 6 hrs 43 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • swhitemd50 swhitemd50 Nov 9, 2011 8:30 AM Flag

    Tomorrow’s Credit Suisse CC

    Hopefully, Vertex will have a better response to questions of future competition from other hep C drug developers. Ian Smith, the CFO, still has 27,793 shares of VRTX so he should have done a better job at the November 8 conference. Sounds like he was praising Pharmasset. In any case, the CFO is probably the worst choice to explain complicated scientific matters regarding hep C drugs in development. I think it is time for Peter Mueller, Vertex's chief scientific officer, to step up and make the case for why Vertex will remain the leader in the treatment of hep C in the short term and the long term.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VRTX
107.25-5.06(-4.51%)Oct 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.